Last updated on February 2017

Phase III, randomized, double-blind, active-controlled, parallel-group study, comparing the efficacy, safety and tolerability of the fixed dose combination of FF/UMEC/VI with the fixed dose dual combination of FF/VI, administered once-daily via a dry powder inhaler in subjects with inadequately controlled ASTHMA.


Brief description of study

Phase III, randomized, double-blind, active-controlled, parallel-group study, comparing the efficacy, safety and tolerability of the fixed dose combination of FF/UMEC/VI with the fixed dose dual combination of FF/VI, administered once-daily via a dry powder inhaler in subjects with inadequately controlled ASTHMA.

Detailed Study Description

This study is comparing a triple fixed-dose combination product compared to a dual fixed-dose combination product in patients with asthma not adequately controlled. This study is for adults age 18 and above.

Clinical Study Identifier: TX147792

Find a site near you

Start Over

Midwest Chest Consultants

330 First Capitol Drive, Suite 470 St. Charles, MO USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.